Are you Dr. Seidman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
110 Irving St Nw
Washington, DC 20010Phone+1 202-877-6190Fax+1 202-877-3820
Summary
- Dr. Jeffrey Seidman, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia, Virginia, and Maryland. He is affiliated with MedStar Washington Hospital Center.
Education & Training
- University of MarylandResidency, Pathology-Anatomic and Clinical, 1988 - 1990
- Georgetown University HospitalInternship, Transitional Year, 1987 - 1988
- State University of New York Downstate Medical Center College of MedicineClass of 1987
Certifications & Licensure
- MD State Medical License 1990 - 2025
- DC State Medical License 1995 - 2014
- VA State Medical License 2012 - 2014
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 6 citationsPathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging.Marios A. Gavrielides, Brigitte M. Ronnett, Russell Vang, Stephanie Barak, Elsie Lee
Archives of Pathology & Laboratory Medicine. 2021-12-01 - 24 citationsFDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L. Osgood, Yutao Gong, Hui Zhang, Erik Bloomquist
Clinical Cancer Research. 2021-04-15 - 77 citationsFDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.Preeti Narayan, Tatiana M. Prowell, Jennifer J Gao, Laura L. Fernandes, Emily Li
Clinical Cancer Research. 2021-04-01